Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Deepesh Lad, Qing Huang, Romy Hoeppli, Rosa Garcia, Lixin Xu, Megan Levings, Kevin Song & Raewyn Broady. (2019) Evaluating the role of Tregs in the progression of multiple myeloma. Leukemia & Lymphoma 60:9, pages 2134-2142.
Read now
Read now
Harshit Khurana, Pankaj Malhotra, Man Updesh Sachdeva, Neelam Varma, Parveen Bose, Uday Yanamandra, Subhash Varma, Alka Khadwal, Deepesh Lad & Gaurav Prakash. (2018) Danazol increases T regulatory cells in patients with aplastic anemia. Hematology 23:8, pages 496-500.
Read now
Read now
Deepesh Lad, Romy Hoeppli, Qing Huang, Rosa Garcia, Lixin Xu, Cynthia Toze, Raewyn Broady & Megan Levings. (2018) Regulatory T-cells drive immune dysfunction in CLL. Leukemia & Lymphoma 59:2, pages 486-489.
Read now
Read now
Deepesh P. Lad, Subhash Varma, Neelam Varma, Man Updesh Singh Sachdeva, Parveen Bose & Pankaj Malhotra. (2015) Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias. Leukemia & Lymphoma 56:8, pages 2424-2428.
Read now
Read now
Wilma Barcellini, Francesca G. Imperiali, Anna Zaninoni, Gianluigi Reda, Dario Consonni, Bruno Fattizzo, Silvia Lonati, Lucia Nobili, Alberto Zanella & Agostino Cortelezzi. (2014) Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression. Leukemia & Lymphoma 55:8, pages 1768-1773.
Read now
Read now
Chava Perry & Aaron Polliack. (2013) Regulatory T cells in chronic lymphocytic leukemia: some progress and a bit of “tolerance” in understanding disease progression. Leukemia & Lymphoma 54:5, pages 903-904.
Read now
Read now
Articles from other publishers (33)
Wael Gamal, Eva Sahakian & Javier Pinilla-Ibarz. (2023) The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?. Blood Advances 7:11, pages 2401-2417.
Crossref
Crossref
Zlatko Roškar, Mojca Dreisinger, Primož Tič, Evgenija Homšak, Sebastjan Bevc & Aleš Goropevšek. (2023) New Flow Cytometric Methods for Monitoring STAT5 Signaling Reveal Responses to SARS-CoV-2 Antigen-Specific Stimulation in FOXP3+ Regulatory T Cells also in Patients with Advanced Chronic Lymphocytic Leukemia. Biosensors 13:5, pages 539.
Crossref
Crossref
Shimrit Ringelstein‐Harlev, Mona Fanadka, Netanel A. Horowitz, Noam P. Bettman & Tami Katz. (2022) In chronic lymphocytic leukemia, activation of the thrombopoietin receptor promotes T‐cell inhibitory properties, contributing to immunosuppression. European Journal of Haematology 110:4, pages 371-378.
Crossref
Crossref
Pavel Vodárek, Dominika Écsiová, Vladimíra Řezáčová, Ondřej Souček, Martin Šimkovič, Doris Vokurková, David Belada, Pavel Žák & Lukáš Smolej. (2022) A comprehensive assessment of lymphocyte subsets, their prognostic significance, and changes after first‐line therapy administration in patients with chronic lymphocytic leukemia. Cancer Medicine 12:6, pages 6956-6970.
Crossref
Crossref
Kamira Maharaj, Angimar Uriepero, Eva Sahakian & Javier Pinilla-Ibarz. (2022) Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies. Frontiers in Immunology 13.
Crossref
Crossref
J. A. C. van Bruggen, G. J. W. van der Windt, M. Hoogendoorn, J. Dubois, Arnon P. Kater & F. S. Peters. (2022) Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells. Blood Advances 6:14, pages 4185-4195.
Crossref
Crossref
Mili Jain, Anushree Rai, Rashmi Kushwaha, Geeta Yadav, Sanjay Mishra, Shailendra Prasad Verma, Uma Shankar Singh, Anil Kumar Tripathi & Ashutosh Kumar. (2021) A Cross Sectional Study on T Cells and Subsets in Chronic Lymphocytic Leukemia and their Association with Clinical Phenotype. Indian Journal of Hematology and Blood Transfusion 37:4, pages 563-568.
Crossref
Crossref
Benedetta Apollonio, Nikolaos Ioannou, Despoina Papazoglou & Alan G. Ramsay. (2021) Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy. Frontiers in Oncology 11.
Crossref
Crossref
Philipp M. Roessner & Martina Seiffert. (2020) T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?. Leukemia 34:8, pages 2012-2024.
Crossref
Crossref
Vitale, Montalbano, Salvetti, Boccellato, Griggio, Boccadoro & Coscia. (2020) Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs. Cancers 12:2, pages 282.
Crossref
Crossref
Priyanka Banerjee, Ronghua Zhang, Cristina Ivan, Giovanni Galletti, Karen Clise-Dwyer, Federica Barbaglio, Lydia Scarfò, Miguel Aracil, Christian Klein, William Wierda, William Plunkett, Federico Caligaris-Cappio, Varsha Gandhi, Michael J. Keating & Maria Teresa S. Bertilaccio. (2019) Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia. Cancer Immunology Research 7:12, pages 2036-2051.
Crossref
Crossref
Iris de WeerdtTom HoflandRenate de BoerJohan A. Dobber, Julie Dubois, Denise van NieuwenhuizeMehrdad MobasherFransien de BoerMels HoogendoornGerjo A. VeldersMarjolein van der KliftEster B. M. Remmerswaal, Frederike J. BemelmanCarsten U. NiemannSabina KerstingMark-David Levin, Eric Eldering, Sanne H. Tonino & Arnon P. Kater. (2019) Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment. Blood Advances 3:17, pages 2642-2652.
Crossref
Crossref
Stephen Man & Peter Henley. (2019) Chronic lymphocytic leukaemia: the role of T cells in a B cell disease. British Journal of Haematology.
Crossref
Crossref
Serena De Matteis, Chiara Molinari, Giulia Abbati, Tania Rossi, Roberta Napolitano, Martina Ghetti, Andrea Ghelli Luserna Di Rorà, Gerardo Musuraca, Alessandro Lucchesi, Gian Matteo Rigolin, Antonio Cuneo, Daniele Calistri, Pier Paolo Fattori, Massimiliano Bonafè & Giovanni Martinelli. (2018) Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients. Journal of Translational Medicine 16:1.
Crossref
Crossref
Daniel R. Bauer, Michael Otter & David R. Chafin. (2018) A New Paradigm for Tissue Diagnostics: Tools and Techniques to Standardize Tissue Collection, Transport, and Fixation. Current Pathobiology Reports 6:2, pages 135-143.
Crossref
Crossref
Vassiliki E. Mpakou, Heleni-Dikaia Ioannidou, Eugene Konsta, Myrofora Vikentiou, Aris Spathis, Frieda Kontsioti, Christos K. Kontos, Athanassios D. Velentzas, Sotiris Papageorgiou, Diamantina Vasilatou, Konstantinos Gkontopoulos, Irene Glezou, Georgia Stavroulaki, Efthimia Mpazani, Stella Kokkori, Elias Kyriakou, Petros Karakitsos, George Dimitriadis & Vasiliki Pappa. (2017) Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia. Leukemia Research 60, pages 74-81.
Crossref
Crossref
Giovanni D’Arena, Candida Vitale, Marta Coscia, Agostino Festa, Nicola Matteo Dario Di Minno, Vincenzo De Feo, Michele Caraglia, Gioacchino Calapai, Luca Laurenti, Pellegrino Musto, Giovanni Di Minno & Daniela Fenoglio. (2017) Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies. Journal of Immunology Research 2017, pages 1-13.
Crossref
Crossref
S Schliffke, N Akyüz, C T Ford, T Mährle, T Thenhausen, A Krohn-Grimberghe, S Knop, C Bokemeyer & M Binder. (2016) Clinical response to ibrutinib is accompanied by normalization of the T-cell environment in CLL-related autoimmune cytopenia. Leukemia 30:11, pages 2232-2234.
Crossref
Crossref
Agnieszka Bojarska-Junak, Piotr Grundszok, Ma?gorzata Waldowska, Justyna Wo?Sylwia Chocholska, Iwona Hus, Wioleta Kowalska, Katarzyna G?ca, Waldemar Tomczak & Jacek Roli?ski. (2016) Monocyty z ekspresj? Tie-2 u chorych na przewlek?? bia?aczk? limfocytow?. Acta Haematologica Polonica 47:3, pages 211-218.
Crossref
Crossref
Kerry A. Rogers & Jennifer A. Woyach. (2016) Secondary autoimmune cytopenias in chronic lymphocytic leukemia. Seminars in Oncology 43:2, pages 300-310.
Crossref
Crossref
David Allard, Bertrand Allard, Pierre-Olivier Gaudreau, Pavel Chrobak & John Stagg. (2016) CD73–adenosine: a next-generation target in immuno-oncology. Immunotherapy 8:2, pages 145-163.
Crossref
Crossref
K A Rogers, A S Ruppert, A Bingman, L A Andritsos, F T Awan, K A Blum, J M Flynn, S M Jaglowski, G Lozanski, K J Maddocks, J C Byrd, J A Woyach & J A Jones. (2015) Incidence and description of autoimmune cytopenias during treatment with ibrutinib for chronic lymphocytic leukemia. Leukemia 30:2, pages 346-350.
Crossref
Crossref
Barbara Sherry, Preetesh Jain, Pui Yan Chiu, Ling Leung, Steven L. Allen, Jonathan E. Kolitz, Kanti R. Rai, Jacquie Barrientos, Spencer Liang, Rachael Hawtin & Nicholas Chiorazzi. (2015) Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes. Immunologic Research 63:1-3, pages 216-227.
Crossref
Crossref
Hollie J Pegram, Eric L Smith, Sarwish Rafiq & Renier J Brentjens. (2015) CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?. Immunotherapy 7:5, pages 545-561.
Crossref
Crossref
Mehdi Yousefi, Ali Akbar Movassaghpour, Karim Shamsasenjan, Ghasem Ghalamfarsa, Sanam Sadreddini, Farhad Jadidi-Niaragh & Mohammad Hojjat-Farsangi. (2015) The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia. Future Oncology 11:10, pages 1567-1582.
Crossref
Crossref
Salah Aref, Emaad Azmy, Hazem Hakim, Tawfik El Khodary, Nadia El Menshawy & Lamiaa Ebrahim. (2014) Regulatory T cells in chronic lymphocytic leukemia. Comparative Clinical Pathology 24:3, pages 649-652.
Crossref
Crossref
Elisa ten Hacken & Jan A. Burger. (2014) Microenvironment dependency in Chronic Lymphocytic Leukemia: The basis for new targeted therapies. Pharmacology & Therapeutics 144:3, pages 338-348.
Crossref
Crossref
Ricardo García Muñoz, Araceli Izquierdo-Gil, Aura Muñoz, Verónica Roldan-Galiacho, Pilar Rabasa & Carlos Panizo. (2014) Lymphocyte recovery is impaired in patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas treated with bendamustine plus rituximab. Annals of Hematology 93:11, pages 1879-1887.
Crossref
Crossref
Carlo Visco, Wilma Barcellini, Francesco Maura, Antonino Neri, Agostino Cortelezzi & Francesco Rodeghiero. (2014) Autoimmune cytopenias in chronic lymphocytic leukemia. American Journal of Hematology 89:11, pages 1055-1062.
Crossref
Crossref
Ricardo García-Muñoz & Luis Llorente. (2014) Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms?. Immunology 142:4, pages 536-550.
Crossref
Crossref
Regina Jitschin, Martina Braun, Maike BüttnerKatja Dettmer-WildeJuliane Bricks, Jana Berger, Michael J. Eckart, Stefan W. Krause, Peter J. OefnerKatarina Le Blanc, Andreas Mackensen & Dimitrios Mougiakakos. (2014) CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood 124:5, pages 750-760.
Crossref
Crossref
Giovanni D'Arena, Roberto Guariglia, Francesco La Rocca, Stefania Trino, Valentina Condelli, Laura De Martino, Vincenzo De Feo & Pellegrino Musto. (2013) Autoimmune Cytopenias in Chronic Lymphocytic Leukemia. Clinical and Developmental Immunology 2013, pages 1-8.
Crossref
Crossref
Dimitrios Vlachakis & Sophia Kossida. (2013) Antibody Drug Conjugate Bioinformatics: Drug Delivery through the Letterbox. Computational and Mathematical Methods in Medicine 2013, pages 1-4.
Crossref
Crossref